01 December 2005
The efficacy of transiently evoked otoacoustic emissions in the detection of middle-ear pathology
Dimitris Davilis, Stavros G. Korres, Dimitrios G. Balatsouras, Eleni Gkoritsa, Giannis Stivaktakis, Eleftherios FerekidisMed Sci Monit 2005; 11(12): MT75-78 :: ID: 438864
Abstract
Background: Transiently evoked otoacoustic emissions (TEOAEs) is an objectivediagnostic method of assessing the cochlear status. The aim of this study was to present the resultsof hearing screening in children and to evaluate TEOAEs in the diagnosis of middle-ear pathology comparedwith tympanometry and pure-tone audiometry. Material/Methods: A group of school-aged children underwentotolaryngological evaluation, tympanometry, TEOAEs, and audiometry. We analyzed data from both ears withabnormal tympanograms and ears with normal tympanograms but abnormal otoscopic findings or positive otologichistory. Included in our study were 497 ears. Results: Two hundred ten (42%) ears had a tympanogram oftype A, 102 (20.5%) of type B, and 185 (37.5%) of type C. Otoacoustic emissions were found in 200 (95%),37 (36%), and 145 (78%) of these ears, respectively. In ears with a tympanogram of B type and presentotoacoustic emissions, a pure-tone average (PTA) worse than 30 dB HL was found in 16 ears (43%), whereasin ears with a tympanogram of B type and absent otoacoustic emissions, PTA worse than 30 dB HL was foundin 47 ears (72.3%). The respective numbers for ears with a tympanogram of C type were 18 (12.4%) and19 (47.5%). Conclusions: TEOAEs may be recorded in significant percentages of ears with abnormal tympanogramsand middle-ear pathology. Although the sensitivity of this method is low, it may be used in conjunctionwith other methods of evaluating the middle ear and may give some information about the hearing statusof the ear.
Keywords: Child, Acoustic Stimulation, Acoustic Impedance Tests, Ear Diseases - diagnosis, Ear, Middle, Evoked Potentials, Auditory
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952